MedPath

US National OCS Heart Perfusion (OHP) Registry

Recruiting
Conditions
Heart Transplant
Registration Number
NCT05915299
Lead Sponsor
TransMedics
Brief Summary

This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.

Detailed Description

The objective of this US National OHP Registry is to collect data on the post-transplant clinical outcomes of all donor hearts preserved and assessed on the OCS Heart System and to document the performance of the OCS Heart device in the real-world setting after FDA approval in the US.

The US National OHP Registry will enroll all heart transplant recipients who are transplanted with an OCS-perfused donor heart in the Registry. Patients' clinical outcomes will be followed up to five years post-transplant, loss to follow up, or death, whichever occurs first.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100000
Inclusion Criteria
  • N/A
Exclusion Criteria
  • N/A

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recipients' patient and graft survivalUp to 5 years post-transplant

Recipients' patient and graft survival rates will be the primary clinical outcomes measures for all OCS Heart transplanted recipients compared to recipients receiving heart transplants using non-OCS preservation methods (cold static storage or other perfusion devices or a combination of both). This data will be obtained directly from UNOS/OPTN database.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

University of California San Diago

🇺🇸

La Jolla, California, United States

Stanford University

🇺🇸

Palo Alto, California, United States

University of California San Francisco

🇺🇸

San Francisco, California, United States

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Mayo Clinic Florida

🇺🇸

Jacksonville, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

Emory University Hospital

🇺🇸

Atlanta, Georgia, United States

University of Chicago

🇺🇸

Chicago, Illinois, United States

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

Scroll for more (22 remaining)
University of California San Diago
🇺🇸La Jolla, California, United States
Andrew Stewart
Contact
Victor Pretorius, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.